Journal ArticleOPEN ACCESS

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis

Open Forum Infectious Diseases (2022) 9(9)
DOI: 10.1093/ofid/ofac440
0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patients with multidrug-resistant tuberculosis who received regimens containing high-dose isoniazid (INHHD) had similar time to culture conversion and treatment outcomes as patients who received regimens with bedaquiline. INHHD is an inexpensive and safe medication that may contribute additive efficacy in combination regimens.

Author supplied keywords

Cite

CITATION STYLE

APA

Walsh, K. F., Vilbrun, S. C., Souroutzidis, A., Ellis, J., Delva, S., Joissaint, G., … Koenig, S. P. (2022). Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis. Open Forum Infectious Diseases, 9(9). https://doi.org/10.1093/ofid/ofac440

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free